Research programme: microbiome targeted therapeutics - Ferring Pharmaceuticals/PharmaBiome
Latest Information Update: 23 Jan 2024
At a glance
- Originator PharmaBiome
- Developer Ferring Pharmaceuticals; PharmaBiome
- Class Bacteria
- Mechanism of Action Gastrointestinal microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Gastrointestinal disorders